New G-CSF agonists for neutropenia therapy.

New G-CSF agonists for neutropenia therapy.

Item
http://www.wikidata.org/entity/Q38145338
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsResults of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancerRole of lipegfilgrastim in the management of chemotherapy-induced neutropeniaTesting stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regenerationA Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized OncologyGranulocyte colony-stimulating factor in the treatment of acute radiation syndrome: a concise review.Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital.Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
P2860

New G-CSF agonists for neutropenia therapy.

Item
http://www.wikidata.org/entity/Q38145338
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New G-CSF agonists for neutropenia therapy.
@en
type
label
New G-CSF agonists for neutropenia therapy.
@en
prefLabel
New G-CSF agonists for neutropenia therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
New G-CSF agonists for neutropenia therapy.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2013.838558
P407
P433
P478
P577
P698